Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Clinicopathological Parameters of HER2 Low Breast Cancers

NCT06433804 is registered in ClinicalTrials.gov with Vardhman Mahavir Medical College And Safdarjung Hospital as lead sponsor.

NCT NCT06433804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06433804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Clinicopathological Parameters of HER2 Low Breast Cancers
Lead sponsor
Vardhman Mahavir Medical College And Safdarjung Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
February 1, 2024
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2 low breast cancers